These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17641531)

  • 1. Metabolic syndrome and dementia risk in a multiethnic elderly cohort.
    Muller M; Tang MX; Schupf N; Manly JJ; Mayeux R; Luchsinger JA
    Dement Geriatr Cogn Disord; 2007; 24(3):185-92. PubMed ID: 17641531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Hibiscus sabdariffa extract powder and preventive treatment (diet) on the lipid profiles of patients with metabolic syndrome (MeSy).
    Gurrola-Díaz CM; García-López PM; Sánchez-Enríquez S; Troyo-Sanromán R; Andrade-González I; Gómez-Leyva JF
    Phytomedicine; 2010 Jun; 17(7):500-5. PubMed ID: 19962289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Incident Dementia According to Metabolic Health and Obesity Status in Late Life: A Population-Based Cohort Study.
    Lee JY; Han K; Han E; Kim G; Cho H; Kim KJ; Lee BW; Kang ES; Cha BS; Brayne C; Lee YH
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2942-2952. PubMed ID: 30802284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study.
    Raffaitin C; Gin H; Empana JP; Helmer C; Berr C; Tzourio C; Portet F; Dartigues JF; Alpérovitch A; Barberger-Gateau P
    Diabetes Care; 2009 Jan; 32(1):169-74. PubMed ID: 18945929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study.
    Boden-Albala B; Sacco RL; Lee HS; Grahame-Clarke C; Rundek T; Elkind MV; Wright C; Giardina EG; DiTullio MR; Homma S; Paik MC
    Stroke; 2008 Jan; 39(1):30-5. PubMed ID: 18063821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study.
    Schilling S; Tzourio C; Soumaré A; Kaffashian S; Dartigues JF; Ancelin ML; Samieri C; Dufouil C; Debette S
    PLoS Med; 2017 Mar; 14(3):e1002265. PubMed ID: 28350817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort.
    Luchsinger JA; Tang MX; Stern Y; Shea S; Mayeux R
    Am J Epidemiol; 2001 Oct; 154(7):635-41. PubMed ID: 11581097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gender-stratified comparative analysis of various definitions of metabolic syndrome and cardiovascular risk in a multiethnic U.S. population.
    Hari P; Nerusu K; Veeranna V; Sudhakar R; Zalawadiya S; Ramesh K; Afonso L
    Metab Syndr Relat Disord; 2012 Feb; 10(1):47-55. PubMed ID: 21999397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome across Europe: different clusters of risk factors.
    Scuteri A; Laurent S; Cucca F; Cockcroft J; Cunha PG; Mañas LR; Mattace Raso FU; Muiesan ML; Ryliškytė L; Rietzschel E; Strait J; Vlachopoulos C; Völzke H; Lakatta EG; Nilsson PM;
    Eur J Prev Cardiol; 2015 Apr; 22(4):486-91. PubMed ID: 24647805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.
    Sattar N; Gaw A; Scherbakova O; Ford I; O'Reilly DS; Haffner SM; Isles C; Macfarlane PW; Packard CJ; Cobbe SM; Shepherd J
    Circulation; 2003 Jul; 108(4):414-9. PubMed ID: 12860911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-life depression, mild cognitive impairment, and dementia.
    Richard E; Reitz C; Honig LH; Schupf N; Tang MX; Manly JJ; Mayeux R; Devanand D; Luchsinger JA
    JAMA Neurol; 2013 Mar; 70(3):374-82. PubMed ID: 23599941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do risk factors for Alzheimer's disease predict dementia in Parkinson's disease? An exploratory study.
    Levy G; Tang MX; Cote LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Mov Disord; 2002 Mar; 17(2):250-7. PubMed ID: 11921109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low blood pressure and the risk of dementia in very old individuals.
    Verghese J; Lipton RB; Hall CB; Kuslansky G; Katz MJ
    Neurology; 2003 Dec; 61(12):1667-72. PubMed ID: 14694027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma homocysteine levels and risk of Alzheimer disease.
    Luchsinger JA; Tang MX; Shea S; Miller J; Green R; Mayeux R
    Neurology; 2004 Jun; 62(11):1972-6. PubMed ID: 15184599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome among Caribbean-born persons living in the U.S. Virgin Islands.
    Tull ES; Thurland A; LaPorte RE
    Rev Panam Salud Publica; 2005 Dec; 18(6):418-26. PubMed ID: 16536928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential tremor is associated with dementia: prospective population-based study in New York.
    Thawani SP; Schupf N; Louis ED
    Neurology; 2009 Aug; 73(8):621-5. PubMed ID: 19704081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low fasting serum insulin and dementia in nondiabetic women followed for 34 years.
    Mehlig K; Lapidus L; Thelle DS; Waern M; Zetterberg H; Björkelund C; Skoog I; Lissner L
    Neurology; 2018 Jul; 91(5):e427-e435. PubMed ID: 29997193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia: Follow-up of the Singapore Longitudinal Ageing Study Cohort.
    Ng TP; Feng L; Nyunt MS; Feng L; Gao Q; Lim ML; Collinson SL; Chong MS; Lim WS; Lee TS; Yap P; Yap KB
    JAMA Neurol; 2016 Apr; 73(4):456-63. PubMed ID: 26926205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Components of metabolic syndrome and 5-year change in insulin clearance - the Insulin Resistance Atherosclerosis Study.
    Lee CC; Lorenzo C; Haffner SM; Wagenknecht LE; Goodarzi MO; Stefanovski D; Norris JM; Rewers MJ; Hanley AJ
    Diabetes Obes Metab; 2013 May; 15(5):441-7. PubMed ID: 23216702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.